eFFECTOR Therapeutics Receives $14,666,666 New Funding

  • Feed Type
  • Date
    7/27/2015
  • Company Name
    eFFECTOR Therapeutics
  • Mailing Address
    11180 Roselle Street San Diego, CA 92121 USA
  • Company Description
    eFFECTOR Therapeutics is pioneering a new class of small molecule drugs that act by selectively regulating translation, also known as protein synthesis. The company unites breakthrough insights into the mechanisms of translational control with a proven approach to product invention.
  • Website
    http://www.effector.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $14,666,666
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing – amended. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy